1992
DOI: 10.1111/j.2042-3306.1992.tb02840.x
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of respiratory infections in horses with ceftiofur sodium

Abstract: Summary Ceftiofur sodium was evaluated as a therapy for respiratory infections in horses. This cephalosporin antimicrobial was administered intramuscularly every 24 h and at a dose of 2.2 mg/kg (1.0 mg/lb) of body weight. The efficacy of ceftiofur sodium was compared with that of a positive control drug, ampicillin sodium (recommended dose of 6.6 mg/kg [3 mg/lb], given every 12 h). Both treatments were continued for 48 h after clinical symptoms were no longer evident (maximum of 10 days). Fifty‐five (55) horse… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
15
0

Year Published

1996
1996
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(17 citation statements)
references
References 3 publications
2
15
0
Order By: Relevance
“…[2][3][4][5][6]7,14 The isolates in this study were from swine and yielded results similar to those using bovine and equine isolates.…”
Section: Resultssupporting
confidence: 58%
“…[2][3][4][5][6]7,14 The isolates in this study were from swine and yielded results similar to those using bovine and equine isolates.…”
Section: Resultssupporting
confidence: 58%
“…Ceftiofur is a bactericidal third-generation cephalosporin that binds to PBPs and prevents bacterial cell wall synthesis (Folz et al 1992;Mahrt 1992;Meyer et al 1992;Cervantes et al 1993;Jaglan et al 1994;Giguere et al 2006).…”
Section: Mode Of Actionmentioning
confidence: 99%
“…[5][6][7][8][9] Bacterial respiratory tract infections in horses are usually precipitated by impairment of local host defenses as a result of viral infections or physiologic stress. 12 For that reason, the therapeutic outcome of respiratory tract infections is typically more closely associated with antimicrobial concentrations in airways than in serum. 12 For that reason, the therapeutic outcome of respiratory tract infections is typically more closely associated with antimicrobial concentrations in airways than in serum.…”
mentioning
confidence: 99%